CTX-009 (ABL001)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CTX-009 (ABL001), covering 2025-01-27 to 2025-01-27. Get the full timeline:
Most recent: Clinical Trial Update: A Study of CTX-009 (ABL001) in Combination With Irinotecan or Paclitaxel in Advanced or Metastatic Solid Tumor Patients [Phase 1, Phase 2]